SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-020261
Filing Date
2014-04-02
Accepted
2014-04-02 16:50:41
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F v373623_20f.htm 20-F 2260806
2 EXHIBIT 10.13 v373623_ex10-13.htm EX-10.13 393539
3 EXHIBIT 10.14 v373623_ex10-14.htm EX-10.14 216288
4 EXHIBIT 21.1 v373623_ex21-1.htm EX-21.1 3477
5 EXHIBIT 23.1 v373623_ex23-1.htm EX-23.1 3315
6 EXHIBIT 23.2 v373623_ex23-2.htm EX-23.2 3629
7 EXHIBIT 31.1 v373623_ex31-1.htm EX-31.1 8083
8 EXHIBIT 31.2 v373623_ex31-2.htm EX-31.2 8579
9 EXHIBIT 32.1 v373623_ex32-1.htm EX-32.1 5043
10 GRAPHIC image_002.jpg GRAPHIC 2302
11 GRAPHIC tlogo1.jpg GRAPHIC 4344
  Complete submission text file 0001144204-14-020261.txt   2913213
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-36000 | Film No.: 14738825
SIC: 2834 Pharmaceutical Preparations